Mahadeo, K. M., Baiocchi, R., Beitinjaneh, A., Chaganti, S., Choquet, S., Dierickx, D., … Prockop, S. (2023). Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE). In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 23, pp. S589–S589).

Mahadeo, K. M., R. Baiocchi, A. Beitinjaneh, S. Chaganti, S. Choquet, D. Dierickx, R. Dinavahi, et al. “Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE).” In AMERICAN JOURNAL OF TRANSPLANTATION, 23:S589–S589, 2023.

Mahadeo KM, Baiocchi R, Beitinjaneh A, Chaganti S, Choquet S, Dierickx D, et al. Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE). In: AMERICAN JOURNAL OF TRANSPLANTATION. 2023. p. S589–S589.

Mahadeo, K. M., et al. “Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE).” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 23, no. 6, 2023, pp. S589–S589.

Mahadeo KM, Baiocchi R, Beitinjaneh A, Chaganti S, Choquet S, Dierickx D, Dinavahi R, Gamelin L, Ghobadi A, Guzman-Becerra N, Joshi A, Mehta A, Nikiforow S, Reshef R, Prockop S. Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE). AMERICAN JOURNAL OF TRANSPLANTATION. 2023. p. S589–S589.